Complete Remission with a Combination of Lenalidomide, Cyclophosphamide and Prednisolone in a Patient with Incomplete POEMS Syndrome

Publisher： Karger

E-ISSN： 1421-9662|126|4|199-201

ISSN： 0001-5792

Source： Acta Haematologica, Vol.126, Iss.4, 2011-08, pp. : 199-201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Complete Remission of del(5q) Myelodysplastic Syndrome after 7 Days of Lenalidomide Therapy Gives an Alert!

By  

Case Reports in Oncology, Vol. 5, Iss. 3, 2012-10 ,pp. : 586-591

Karger

Access to resources Recommend Favorite

Long-Term Complete Remission with nab-Paclitaxel, Bevacizumab, and Gemcitabine Combination Therapy in a Patient with Triple-Negative Metastatic Breast Cancer

By  

Case Reports in Oncology, Vol. 5, Iss. 3, 2012-12 ,pp. : 687-692

Karger

Access to resources Recommend Favorite

Maintenance lenalidomide in combination with 5‐azacitidine as post‐remission therapy for acute myeloid leukaemia

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 2, 2015-04 ,pp. : 199-210

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Case of Plasmablastic Lymphoma Achieving Complete Response and Durable Remission after Lenalidomide-Based Therapy

By  

Oncology Research and Treatment, Vol. 40, Iss. 1-2, 2017-01 ,pp. : 46-48

Karger

Access to resources Recommend Favorite

Megakaryocytes harbour the del(5q) abnormality despite complete clinical and cytogenetic remission induced by lenalidomide treatment

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 4, 2018-02 ,pp. : 526-533

John Wiley & Sons Inc

Access to resources Recommend Favorite